# Oral Dosage Form New Animal Drugs; Oxibendazole Suspension
> **Food and Drug Administration** · Final rule. · Published 2006-06-08 · Effective 2006-06-08 · 71 FR 33237
## Document
- **Document number:** E6-8953
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 71 FR 33237
- **CFR reference:** 21 CFR 520
- **Publication date:** 2006-06-08
- **Effective date:** 2006-06-08
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pfizer, Inc. The supplemental NADA provides for revised food safety labeling for oxibendazole suspension administered orally to horses as an antiparasitic.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2006/06/08/E6-8953/oral-dosage-form-new-animal-drugs-oxibendazole-suspension)
---
*AI Analytics · CC0 1.0*